BFA
NVCR icon

BlackRock Fund Advisors’s NovoCure NVCR Stock Holding History

BlackRock Fund Advisors’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$21.1M Buy
2,691,801
+1,415,536
+111% +$11.4M ﹤0.01% 2153
2016
Q3 		$10.9M Buy
1,276,265
+83,967
+7% +$766K ﹤0.01% 2416
2016
Q2 		$13.9M Buy
1,192,298
+995,813
+507% +$12.5M ﹤0.01% 2229
2016
Q1 		$2.85M Sell
196,485
-10,061
-5% -$144K ﹤0.01% 2978
2015
Q4 		$4.62M Buy
+206,546
New +$4.93M ﹤0.01% 2874

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HCM
Highline Capital Management New York $53.5M AUM 21.72% 1-Year Est. Return
SG
StepStone Group La Jolla, California $2.16B AUM 20.11% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
CCM
Courage Capital Management Nashville, Tennessee $67.3M AUM 9.93% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

BlackRock Fund Advisors's NVCR Position: Q4 2016 in Review

BlackRock Fund Advisors increased its NovoCure (NVCR) stake by 111% in Q4 2016, buying an estimated $11.4M and bringing the position to 2,691,801 shares worth $21.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2153.

BlackRock Fund Advisors first reported a position in NVCR in Q4 2015 and has held it in 5 quarters since. 78 funds tracked by Wall St. Rank hold NVCR as of Q4 2016.

  • BlackRock Fund Advisors held 2,691,801 shares of NovoCure worth $21.1M as of Q4 2016.
  • BlackRock Fund Advisors bought 1,415,536 NovoCure shares in Q4 2016, an estimated $11.4M.
  • NovoCure made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #2153 holding.
  • BlackRock Fund Advisors first reported a position in NovoCure in Q4 2015 and has held it in 5 quarters since.
  • 78 funds tracked by Wall St. Rank held NovoCure as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.